Drug Type Small molecule drug |
Synonyms BTQ-1901 |
Target |
Mechanism β-adrenoceptors antagonists(Beta adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Betaliq, Inc.Startup |
Active Organization- |
Inactive Organization Betaliq, Inc.Startup |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma | Discovery | US | Betaliq, Inc.Startup | 25 Apr 2019 |